A board member and former chairman of the federal National Credit Union Administration (NCUA) is sharply criticizing Congress for failing to reform marijuana laws, and he announced on Thursday that he will be taking steps to push lawmakers to enact policy changes to help financial institutions and stakeholders caught in the federal-state cannabis conundrum.
NCUA’s Rodney Hood said at the PBC Conference that he’s “concerned that the legal and regulatory infrastructure surrounding the cannabis industry is not evolving quickly enough,” and congressional inaction is largely to blame. He also said that he feels legalization at the federal level is an inevitability.
A bill to legalize the possession of psychedelics in California has been put on pause until next year, but the Senate sponsor says the move is part of the “complicated legislative process” to get reform enacted—and he’s confident it will ultimately prevail.
A group of lawmakers in Rhode Island are rallying behind a set of key equity principles they want to see in marijuana legalization legislation—and they’re urging colleagues to convene a special session to see their vision through.
Wyoming activists are kicking it into high gear to collect signatures for 2022 ballot initiatives to legalize medical marijuana and decriminalize cannabis possession, with the campaign announcing a series of events this weekend to shore up support.
Federal health officials on Thursday delayed a high-stakes decision on whether to permit bestselling vaping brand Juul to stay on the market, while banning the sale of thousands of other electronic cigarettes.
The Food and Drug Administration said it rejected applications for nearly 950,000 e-cigarettes and related products, mainly due to their potential appeal to underage teens. Some of the products are currently being sold while many others were only proposed by manufacturers. But the agency didn’t rule on Juul, the most popular brand with adult smokers and many teens.
A panel tasked with studying treatment of those with mental health disorders in the criminal justice system is calling for a 10% cap on THC potency for medical cannabis
New Mexico releases emergency amendments to its cannabis rules.
The use of cannabidiol (CBD) for animal species is an area of growing interest, for example for its anti-inflammatory and immuno-modulating properties, even though all of its biological effects are still not fully understood, especially in veterinary medicine. Therefore, the aim of this study was to investigate the anti-inflammatory and immuno-modulating properties of CBD for the first time directly in canine inflammatory response. We used an ex vivo model of LPS-stimulated whole dog blood. We stimulated the whole blood from healthy dogs with LPS 100 ng/mL for 24 h in the presence or not of CBD 50 and 100 μg/mL. We observed a reduction in IL-6 and TNF-α production from the group treated with CBD, but non-altered IL-10 levels. Moreover, we also observed from the CBD-treated group a reduction in Nf-κB and COX-2 expression. In conclusion, we demonstrated for the first time the anti-inflammatory and immuno-modulating properties of CBD directly in dogs’ immune cells, using a canine ex vivo inflammatory model. The results obtained from these studies encourage further studies to better understand the possible therapeutic role of CBD in veterinary medicine.
Likes: 0
Viewed: 3
source